Home > Business > Bacteriophage Therapy Market Research Report, Share, and Forecast to 2025

Bacteriophage Therapy Market Research Report, Share, and Forecast to 2025

Added: (Fri Jul 19 2019)

Pressbox (Press Release) - Bacteriophages (or “phages”) are viruses that can be found inside plants and animals and in soil, rivers, oceans and even sewers. Phages invade bacterial cells and inject their DNA into the bacterial target. Some phages can disrupt bacterial metabolism and cause the bacterium to disintegrate. The intentional application of phages to destroy bacteria is known as bacteriophage therapy. Because phages attack bacteria and are strain-specific, they are thought to be harmless to humans. An added benefit of the strain-specific nature of phages is that they do not disrupt the natural flora that are beneficial in the body.

Bacteriophage therapy Market was valued at US$ XX Mn in 201X and expected to grow at X% Compound Annual Growth Rate (CAGR) over 201X to 202X
Bacteriophage therapy or phage therapy is used to treat the pathogenic bacterial infections with viruses. These are more specific than bacteria and do not cause any harm to host organism as well as beneficial bacteria such as gut flora. Bacteriophages are most abundant in biosphere and isolated, concentrated, and applied in specific area to eradicate the bacteria. They cause the bacterium to lyse by disrupting the bacterial metabolism. The major advantages with bacteriophages over the antibiotics include very specific, replicate at the site of infection, less side effects and rapidly select the new phages. Bacteriophages can be administered by oral, rectal, intravenous, intrapleural injections, and local applications.
The strengthening factor in the Bacteriophage therapy Increase in the incidence of antibiotic resistant bacteria. FDA approval for bacteriophage therapies, stringent regulations for the use of antibiotics, promising pipeline drugs under various stages of clinical trials, rise in funding from the public and private sector for bacteriophage therapy research, and wide range of applications with bacteriophage therapeutics are propel the bacteriophage therapy market over the forecast years.
Moreover, most of the bacteriophage therapy market players and research institutes are focused on the R&D activities to develop newer bacteriophage therapies to treat the chronic infections. For instance,

Precision Business Insights (PBI) in its report titled “Bacteriophage Therapy Market”: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 20XX-20XX and Forecast 20XX-20XX” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast.

• AmpliPHI Bioscieces Corporation developing the bacteriophage therapeutics AB-SA01 and AB-PA01. AB-SA01 is developed for the treatment of multi drug resistant aureus infections and completed the two Phase 1 studies. AB-PA01 developed for the treatment of P. aeruginosa infections and completed the pre-clinical studies

For request sample: https://precisionbusinessinsights.com/request-sample/?product_id=23847

• Technophage received FDA clearance for its Investigational New Drug (IND) application to initiate the human clinical trials for bacteriophage TP-102 used in the treatment of chronic ulcers such as diabetic foot disease

• In January 2018, Pherecydes Pharma raised US$ 10.3 Mn Series B funding led by GO CAPITAL, ACE Management, and Auriga Partners to enter the clinical trials novel bacteriophages PHOSA for the treatment of Staphylococcus aureus infection and PNEUMOPHAGE for the treatment of Pseudomonas aeruginosa respiratory tract infections.

• In March 2017, Intralytix, Inc. received GRAS recognition from FDA for ShigaShield, a non-chemical antimicrobial preparation to control waterborne/foodborne bacterial pathogen Shigella including three major disease-causing species S, sonnei, S. flexneri, and S. dysenteriae. Moreover, company collaborated with Ferring Pharmaceuticals in bacteriophage-based inflammatory bowel disease (IBD) drug development project
For more information: https://precisionbusinessinsights.com/market-reports/bacteriophage-therapy-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

Submitted by:Rekha
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.